Mah, India

Dharmaraj R Rao


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 58(Granted Patents)


Location History:

  • Thane, IN (2002)
  • Mah, IN (2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Compositions by Dharmaraj R Rao

Introduction

Dharmaraj R Rao is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new polymorphic forms of olanzapine. With a total of two patents to his name, his work focuses on improving treatment options for various psychotic conditions.

Latest Patents

R Rao's latest patents include innovative pharmaceutical compositions that contain new polymorphic forms of olanzapine. These compositions are particularly useful for treating psychotic conditions, mild anxiety, and gastrointestinal issues. His inventions specifically address the treatment of schizophrenia, acute mania, Bipolar I Disorder, psychotic mood disorder, and psychosis in patients with Alzheimer's disease. The patents detail three new polymorphic forms of olanzapine, along with the processes for preparing these polymorphs and the pharmaceutical compositions that incorporate them.

Career Highlights

R Rao is associated with U & I Pharmaceuticals, Ltd., where he continues to advance his research and development efforts. His work has the potential to significantly impact the pharmaceutical industry by providing new treatment options for patients suffering from severe mental health conditions.

Collaborations

Some of his notable coworkers include Yusuf Khwaja Hamied and Rajendra N Kankan, who have also contributed to advancements in pharmaceutical research.

Conclusion

Dharmaraj R Rao's innovative work in the field of pharmaceuticals exemplifies the importance of research and development in creating effective treatments for complex health issues. His contributions are paving the way for improved therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…